Home
Storia in 1 fonti
Weight loss, muscle mass, heart risk: Study decodes strengths & weaknesses of 19 GLP-1 drugs
Tirzepatide burns most fat and muscle; semaglutide cuts death, heart attack and kidney risk, and jury is out on whether they improve quality of life | India News
Raccontata da
hindustantimes.com
Timeline cronologica
- ·
Gains clear, but no single GLP-1 or other weight loss drug wins on every count: Study
A comprehensive analysis of 19 obesity drugs reveals no single standout, with weight loss often accompanied by muscle loss and side effects.
- ·
Weight loss, muscle mass, heart risk: Study decodes strengths & weaknesses of 19 GLP-1 drugs
Tirzepatide burns most fat and muscle; semaglutide cuts death, heart attack and kidney risk, and jury is out on whether they improve quality of life | India News